Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Fulvning Granules** is a regulated Traditional Chinese Medicine hospital preparation developed at Longhua Hospital, Shanghai University of Traditional Chinese Medicine. It is an orally administered multicomponent herbal preparation used as an adjunct to guideline-directed conventional treatment for symptomatic atrial fibrillation, particularly in Traditional Chinese Medicine patterns involving qi and yin deficiency. In a randomized, double-blind, placebo-controlled study of 136 symptomatic atrial-fibrillation patients treated for 4 weeks, Fulvning Granules improved Holter-defined atrial-fibrillation control and reduced palpitation frequency and duration versus placebo. Untargeted metabolomics associated treatment with changes in ketone-body, butanoate, and glycerophospholipid metabolic pathways; however, no validated discrete molecular drug target has been established. ([frontiersin.org](https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1761563/full))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fulvning Granules.